Settlement Agreements, Prestigious Recognitions, Proposed M&A's, and ...

28-11-2013 PR NewswireComments (0)

PharmaceuticalVanda Pharmaceuticals

On November 15, 2013, Bloomberg reported that Vanda Pharmaceuticals Inc. (Vanda) has won the backing of U.S. advisers for an experimental drug known as tasimelteon, to regulate the circadian rhythms of blind people to help them sleep. According to the ...

Read more on PR Newswire

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top